Literature DB >> 5428043

Experiences with a rat bio-assay in the diagnosis of the Zollinger-Ellison syndrome.

C G Thomson, I G Cleator, W Sircus.   

Abstract

Reported here are the assay results, using the anaesthetized rat preparation of Lai (1964), of plasma from patients known or suspected to have peptide-secreting adenomata and these are compared with assays carried out on plasma from patients whose clinical history excluded such pathology. It is suggested that these demonstrate that this technique is of diagnostic value in this condition and that it has practical advantages over other bio-assay methods currently available and physiological advantages over immunological methods. It may well be that identification of the presence of tumour in these patients may first be made by immunological techniques to be followed by functional identification using a bioassay procedure such as is described here.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5428043      PMCID: PMC1411560          DOI: 10.1136/gut.11.5.409

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

1.  CIRCULATING GASTRIC SECRETOGOGUE IN ZOLLINGER-ELLISON SYNDROME.

Authors:  S BANK; I N MARKS
Journal:  Lancet       Date:  1964-11-07       Impact factor: 79.321

2.  EVIDENCE FOR A GASTRIC SECRETAGOGUE IN THE CIRCULATION AND GASTRIC JUICE OF PATIENTS WITH ZOLLINGER-ELLISON SYNDROME.

Authors:  W SIRCUS
Journal:  Lancet       Date:  1964-09-26       Impact factor: 79.321

3.  GASTRIN ACTIVITY OF TUMOUR TISSUEIN A CHILD WITH THE ZOLLINGER-ELLISON SYNDROME.

Authors:  R H JACKSON; E L BLAIR; P J DAWSON; J D REED; W P WATTS
Journal:  Lancet       Date:  1963-11-02       Impact factor: 79.321

4.  A method for biologic assay of gastrin.

Authors:  B UVNAS; S EMAS
Journal:  Gastroenterology       Date:  1961-05       Impact factor: 22.682

5.  Immunological study in the Zollinger-Ellison syndrome.

Authors:  A P MONACO; J P LYTHGOE; W R WADDELL
Journal:  Lancet       Date:  1961-11-04       Impact factor: 79.321

6.  The estimation of gastrin activity in blood.

Authors:  E L Blair; D D Wood
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

7.  Peptide-seceting adenomata with special reference to the Zollinger-Ellison syndrome.

Authors:  W Sircus
Journal:  Postgrad Med J       Date:  1968-09       Impact factor: 2.401

8.  Effects of SC 15396 on gastric secretion. 3. The action in the rat.

Authors:  C G Thomson; W Sircus
Journal:  Gut       Date:  1968-12       Impact factor: 23.059

9.  STUDIES ON GASTRIN.

Authors:  S K LAI
Journal:  Gut       Date:  1964-08       Impact factor: 23.059

10.  Assay of gastrin by means of its gastric acid stimulating activity.

Authors:  E L Blair; R M Keenlyside; D J Newell; J D Reed; D D Richardson
Journal:  J Physiol       Date:  1968-10       Impact factor: 5.182

View more
  3 in total

1.  Anastomotic ulceration.

Authors:  I G Cleator; I B Holubitsky; R C Harrison
Journal:  Ann Surg       Date:  1974-03       Impact factor: 12.969

2.  The technique and clinical application of the cytochemical section bioassay for gastrin-like activity.

Authors:  R W Hoile
Journal:  Ann R Coll Surg Engl       Date:  1982-03       Impact factor: 1.891

3.  The detection and measurement of circulating gastrin-like activity by bioassay.

Authors:  D G Colin-Jones; J E Lennard-Jones
Journal:  Gut       Date:  1972-02       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.